Home
Who we are
Pipeline
News
Contact
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Our mission is is to develop essential medicines to improve
care and support of pediatric orphan diseases.
Latest news and reports
Latest news and report
30 octobre 2018
ORPHELIA at the 2018 SIOP meeting in Kyoto (Japan)
Read more
30 octobre 2018
ORPHELIA at Bioeurope in Copenhagen, Denmark
Read more
22 octobre 2018
ORPHELIA Pharma has been awarded a €1m loan from Bpifrance
Read more
1 octobre 2018
Granting of the marketing authorization for Kigabeq®
Read more
28 août 2018
ORPHELIA Pharma will be present at CPhI in Madrid
Read more
28 août 2018
CHMP has adopted a positive opinion for Kigabeq®
Read more
25 juin 2018
Pierre Attali joins ORPHELIA Pharma Board Of Directors
Read more
28 mars 2018
ORPHELIA at the 2018 BIO Convention in Boston
Read more
